LabCorp's Liquid Yield Option(TM) Notes To Accrue Contingent Cash Interest

BURLINGTON, N.C., Sept. 19 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) announced today that for the period of September 12, 2006 to March 11, 2007, its $744 million in zero coupon subordinated Liquid Yield Option(TM) Notes (LYONs) due 2021 will,

LabCorp is Scheduled to Present at the Bank of America 36th Annual Investment Conference

BURLINGTON, N.C., Sept. 18 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that David P. King, Executive Vice President and Chief Operating Officer, Bradford T. Smith, Executive Vice President, Corporate Affairs, and William (Brad)

LabCorp is Scheduled to Present at the Thomas Weisel Partners Healthcare Conference

BURLINGTON, N.C., Sept. 6 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that David P. King, Executive Vice President and Chief Operating Officer, Bradford T. Smith, Executive Vice President, Corporate Affairs, and William (Brad)

Laboratory Corporation of America(R) Announces 2006 Second Quarter Results

EBITDA Margin of 27.3 Percent Drives Operating Cash Flow of $128.5 million and EPS Increase of 14.5 Percent BURLINGTON, N.C., July 25 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced results for the quarter and six-months ended June 30,

LabCorp(R) Announces Succession Plan; David P. King to Succeed Thomas P. Mac Mahon as CEO on January 1, 2007

Mac Mahon to Remain Chairman of the Board of Directors until 2008 Annual Shareholders' Meeting; Bradford T. Smith Appointed to the Board of Directors as Vice Chairman Effective January 1, 2007 BURLINGTON, N.C., July 21 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings

LabCorp(R) and Duke University Collaborate to Offer New Genomic Tests

BURLINGTON, N.C., June 13 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH), a national leader in esoteric testing, today announced an important new relationship that will help it expand its opportunities to offer new genomic tests by partnering with

LabCorp Is Scheduled To Present at the Bank of America Health Care Conference

BURLINGTON, N.C., May 16 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that Bradford T. Smith, Executive Vice President, Corporate Affairs, and William (Brad) Hayes, Executive Vice President and Chief Financial Officer, are scheduled

LabCorp(R) Scheduled To Webcast Its Annual Meeting of Stockholders

BURLINGTON, N.C., May 15 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that its Annual Meeting of Shareholders will be webcast live beginning May 17, 2006 at 9:00 a.m. Eastern Time via the Company web site at www.labcorp.com.

LabCorp(R) Advances Leadership Position in Drug Metabolism Testing With Expanded Services for Physicians Prescribing and Dosing Drugs

New Tool - Signature Genetics(TM) Drug Response Interpretation Service - Helps Physicians Make Better Drug Treatment Decisions BURLINGTON, N.C., May 3, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH), a national leader in

Laboratory Corporation of America(R) Holdings Announces 2006 First Quarter Results

Revenue Growth of 9.9% Drives Operating Cash Flow of $178.6 Million BURLINGTON, N.C., April 25, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced results for the first quarter ended March 31, 2006.